Article Information
History
- August 28, 2020.
Article Versions
- Version 1 (May 27, 2020 - 10:09).
- Version 2 (May 28, 2020 - 01:04).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nancy G. Azizian1,2,
- Delaney K. Sullivan3,
- Litong Nie4,
- Sammy Pardo5,
- Dana Molleur5,
- Junjie Chen4,
- Susan T. Weintraub5 and
- Yulin Li1,2,*
- 1Center for Immunotherapy Research, Houston Methodist Research Institute, Houston, TX 77030, USA
- 2Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
- 3UCLA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
- 4Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 5Department of Biochemistry and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
- ↵*Corresponding author
: Yulin Li, Houston Methodist Research Institute. 6670 Bertner Avenue. Houston, TX 77030, USA. Phone: 713-441-7350; Fax: 713-441-7438; Email: yli{at}houstonmethodist.org